Skip to content
Webe Honey – Lifestyle
Author:
NOVAVAX, INC
Novavax Earns $125 Million Milestone as Sanofi Launches Phase 3 Influenza-COVID-19 Combination Vaccine Trial in Europe
October 29, 2026
Novavax to Report Third Quarter 2026 Financial Results on November 5, 2026
October 29, 2026
Novavax to Participate in September Investor Conferences
September 2, 2026
Novavax Reports Second Quarter 2026 Financial Results and Operational Highlights
August 6, 2026
Novavax to Report Second Quarter 2026 Financial Results on August 6, 2026
July 30, 2026
Novavax to Participate in 2026 Jefferies Global Healthcare Conference
June 1, 2026